Effect of coiled-coil peptides on the function of the type III secretion system-dependent activity of enterohemorragic Escherichia coli O157: H7 and Citrobacter rodentium

International Journal of Medical Microbiology

Volumn 303, Issue 1, 2013, Pages 9-15

  Larzábal, Mariano ^a   Zotta, Elsa ^b   Ibarra, Cristina ^b   Rabinovitz, Bettina C ^a   Vilte, Daniel A ^a   Mercado, Elsa C ^a   Cataldi, Ángel ^a  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

C. rodentium; Coiled coil; EHEC; Peptides; TTSS

Indexed keywords

BACTERIAL PROTEIN; ESCHERICHIA COLI SECRETED PROTEIN A; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITROBACTER RODENTIUM; COLON INJURY; CONTROLLED STUDY; ESCHERICHIA COLI O157; FEMALE; FLUID INTAKE; HEMOLYSIS; IN VIVO STUDY; INFLAMMATORY INFILTRATE; INTESTINE INJURY; LISTLESSNESS; MOUSE; NONHUMAN; TYPE III SECRETION SYSTEM;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; CITROBACTER RODENTIUM; COLON; ENTEROBACTERIACEAE INFECTIONS; ERYTHROCYTES; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; FEMALE; HEMOLYSIS; HUMANS; INTESTINES; MICE; MICE, INBRED C57BL; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT;

EID: 84872933512     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2012.12.001     Document Type: Article

References (30)

1. Borenshtein D., McBee M.E., Schauer D.B. Utility of the Citrobacter rodentium infection model in laboratory mice. Curr. Opin. Gastroenterol. 2008, 24:32-37.
2. Elliott S.J., Wainwright L.A., McDaniel T.K., Jarvis K.G., Deng Y.K., Lai L.C., McNamara B.P., Donnenberg M.S., Kaper J.B. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol. Microbiol. 1998, 28:1-4.
3. Gardiner G.E., O'Flaherty S., Casey P.G., Weber A., McDonald T.L., Cronin M., Hill C., Ross R.P., Gahan C.G., Shanahan F. Evaluation of colostrum-derived human mammary-associated serum amyloid A3 (M-SAA3) protein and peptide derivatives for the prevention of enteric infection: in vitro and in murine models of intestinal disease. FEMS Immunol. Med. Microbiol. 2009, 55:404-413.
4. Ide T., Laarmann S., Greune L., Schillers H., Oberleithner H., Schmidt M.A. Characterization of translocation pores inserted into plasma membranes by type III-secreted Esp proteins of enteropathogenic Escherichia coli. Cell. Microbiol. 2001, 3:669-679.
5. Johnson-Henry K.C., Nadjafi M., Avitzur Y., Mitchell D.J., Ngan B.Y., Galindo-Mata E., Jones N.L., Sherman P.M. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J. Infect. Dis. 2005, 191:2106-2117.
6. Karch H., Tarr P.I., Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 2005, 295:405-418.
7. Kenny B., DeVinney R., Stein M., Reinscheid D.J., Frey E.A., Finlay B.B. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 1997, 91:511-520.
8. Kenny B., Lai L.C., Finlay B.B., Donnenberg M.S. EspA, a protein secreted by enteropathogenic Escherichia coli, is required to induce signals in epithelial cells. Mol. Microbiol. 1996, 20:313-323.
9. Kimura K., Iwatsuki M., Nagai T., Matsumoto A., Takahashi Y., Shiomi K., Omura S., Abe A. A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium. J. Antibiot. (Tokyo) 2011, 64:197-203.
10. Knutton S., Rosenshine I., Pallen M.J., Nisan I., Neves B.C., Bain C., Wolff C., Dougan G., Frankel G. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 1998, 17:2166-2176.
11. Laaberki M.H., Janabi N., Oswald E., Repoila F. Concert of regulators to switch on LEE expression in enterohemorrhagic Escherichia coli O157:H7: interplay between Ler, GrlA, HNS and RpoS. Int. J. Med. Microbiol. 2006, 96:197-210.
12. Larzábal M., Mercado E.C., Vilte D.A., Salazar-González H., Navarro-García F., Cataldi A. Designed coiled-coil peptides inhibit the type three secretion system of enteropathogenic Escherichia coli. PLoS ONE 2010, 4(5):e9046.
13. Levine M.M., Bergquist E.J., Nalin D.R., Waterman D.H., Hornick R.B., Young C.R., Sotman S. Escherichia coli that cause diarrhea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet 1978, 1(8074):1119-1122.
14. Maaser C., Housley M.P., Iimura M., Smith J.R., Vallance B.A., Finlay B.B., Schreiber J.R., Varki N.M., Kagnoff M.F., Eckmann L. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect. Immun. 2004, 72:3315-3324.
15. McDaniel T.K., Jarvis K.G., Donnenberg M.S., Kaper J.B. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. USA 1995, 92:1664-1668.
16. Miliwebsky E., Deza N., Chinen I., Martinez Espinosa E., Gomez D., Pedroni E., Caprile L., Bashckier A., Manfredi E., Leotta G., Rivas M. Prolonged fecal shedding of Shiga toxin-producing Escherichia coli among children attending day-care centers in Argentina. Rev. Argent. Microbiol. 2007, 39:90-92.
17. Mundy R., MacDonald T.T., Dougan G., Frankel G., Wiles S. Citrobacter rodentium of mice and man. Cell. Microbiol. 2005, 7:1697-1706.
18. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 1998, 11:142-201.
19. Repetto H.A. Long-term course and mechanisms of progression of renal disease in haemolytic uremic syndrome. Kidney Int. Suppl. 2005, 97:S102-S106.
20. Ritchie J.M., Waldor M.K. The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits. Infect. Immun. 2005, 73:1466-1474.
21. Schauer D.B., Falkow S. Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect. Immun. 1993, 61:2486-2492.
22. Sekiya K., Ohishi M., Ogino T., Tamanoi K., Sasakawai C., Abe A. Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc. Natl. Acad. Sci. USA 2001, 98:11638-11643.
23. Tree J.J., Wolfson E.B., Wang D., Roe A.J., Gally D.L. Controlling injection: regulation of type III secretion in enterohaemorrhagic Escherichia coli. Trends Microbiol. 2009, 17:361-370.
24. Uren T.K., Wijburg O.L., Simmons C., Johansen F.E., Brandtzaeg P., Strugnell R.A. Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies. Eur. J. Immunol. 2005, 35:180-188.
25. Vallance B.A., Finlay B.B. Exploitation of host cells by enteropathogenic Escherichia coli. Proc. Natl. Acad. Sci. USA 2000, 97:8799-8806.
26. Varcoe J.J., Krejcarek G., Busta F., Brady L. Prophylactic feeding of Lactobacillus acidophilus NCFM to mice attenuates overt colonic hyperplasia. J. Food Prot. 2003, 66:457-465.
27. Wainwright L.A., Kaper J.B. EspB and EspD require a specific chaperone for proper secretion from enteropathogenic Escherichia coli. Mol. Microbiol. 1998, 27:1247-1260.
28. Warawa J., Finlay B.B., Kenny B. Type III secretion-dependent hemolytic activity of enteropathogenic Escherichia coli. Infect. Immun. 1999, 67:5538-5540.
29. Wieler L.H., McDaniel T.K., Whittam T.S., Kaper J.B. Insertion site of the locus of enterocyte effacement in enteropathogenic and enterohemorrhagic Escherichia coli differs in relation to the clonal phylogeny of the strains. FEMS Microbiol. Lett. 1997, 156:49-53.
30. Wiles S., Dougan G., Frankel G. Emergence of a 'hyperinfectious' bacterial state after passage of Citrobacter rodentium through the host gastrointestinal tract. Cell. Microbiol. 2005, 7:1163-1172.